Call-n-Trade : +91 22-6133 9800
(Press 1 & 1)
Customer Service : +91 22-6138 9389
GET QUOTES
All Services
Equity
  Daily Market Tracker
  Market Analysis
  Corporate Information
  Corporate Actions
   Announcements
  Book Closure
  Board Meetings
  Bonus Issues
  Rights Issues
  De-Listed Shares
  Market Turnover
  Change of Name
  Split of Face Value
Derivatives
News
  Other Markets
  Home    Markets    Equity    Corporate Actions    Announcements
Announcements
Exchange :
Apollo Tyres

Apollo Tyres will hold a meeting of the Board of Directors of the Company on 13 November 2018.

Apple Finance

Apple Finance will hold a meeting of the Board of Directors of the Company on 14 November 2018.

Cipla

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets 450mg from the United States Food and Drug Administration (US FDA).

Cipla's Valganciclovir Tablets 450mg is AB-rated generic therapeutic equivalent version of Roche's Valcyte®. It is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for use in the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk.

CG Power & Indu.

CG Power & Industrial Solutions will hold a meeting of the Board of Directors of the Company on 13 November 2018.

DCW

DCW will hold a meeting of the Board of Directors of the Company on 15 November 2018.

 123456 
How We Help?
Delivery Based Trading
Intra Day Trading
BITSIT®
Futures and Options
Applying IPO Online
Applying MF Online
NRI Services
Mutual Fund Distribution
Back office
Digital Contracts
Research
Do’s and Don’ts
Equity
Daily Market Tracker
Market Analysis
Company Info
News Analysis
Corporate Announcement
Global Indices
 
Derivatives
Derivative
Futures
Options
IPOs
Forthcoming Issues
Open Issues
Closed Issues
New Issue Monitor
New Listing
Basis of Allotment
Draft Prospectus
Best Performers
Know IPO's / FAQ's
Mutual Funds
MF Schemes
MF Trends
MF Buzz
MF Tools
Knowledge Center
Other Links
About Us
Contact Us
Sitemap
FAQs
Disclaimer
Trading Holidays
Investor Grievance
Rules & Regulations
Privacy Policy
Password Policy
Terms of Use
Rights & Obligations (Vernacular Language)
Criteria for Fit and Proper person
Other Links
RBI |  SEBI |  BSE |  NSE
CDSL |  NSDL
BANK OF BARODA
BOBIBANKING
BOB CAPITAL MARKETS LTD
BOB CARDS
BARODA PIONEER MUTUAL FUND
INDIAFIRST LIFE INSURANCE
RGESS
© 2014 BOB CAPITAL MARKETS LTD. All rights reserved
SEBI Single Registration Certificate - INZ000159332
Designed, Developed and Content provided by C-MOTS Infotech (ISO 9001:2008 certified)
Site best viewed in IE 7.0+, Netscape 8.1 and Mozila Firefox 1.5+ at 1024 x 768 pixels resolution.
Compliance Officer: Shri. Pushkar Vartak / Phone : 022 – 6138 9321 / email : compliance@bobcaps.in